MedPath

B3 Buddy for Securing Urinary Drainage Bag to Patient While Walking

Not Applicable
Completed
Conditions
Urinary System Disorder
Interventions
Other: Assistance
Other: Educational Intervention
Other: Medical Device Usage and Evaluation
Other: Questionnaire Administration
Other: Walking
Procedure: Remove
Registration Number
NCT06571058
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Brief Summary

This clinical trial tests how well the Bag Below Bladder (B3) Buddy device works in securing urinary drainage bags while walking. Keeping a urinary drainage bag below the bladder is the standard of care to maintain urine flow and prevent urine from backing up into the bladder. Despite the use of modern urinary drainage bags for over 60 years, workarounds, including hooking the bag into pants pockets, are being used to secure the bags while walking. The B3 Buddy may help keep the urinary drainage bag at the proper level for drainage while walking.

Detailed Description

PRIMARY OBJECTIVES:

I. To evaluate the acceptability of the B3 Buddy, from the patient's perspective.

II. To evaluate the usability of the B3 Buddy, from the clinician's perspective.

OUTLINE: Patients are assigned to 1 of 2 groups.

PATIENTS: Patients receive a short instructional session, wear the B3 Buddy device to secure urinary drainage bag and walk approximately 90 feet before urinary drainage bag is returned to the standard position on study.

CLINICIANS: Clinicians receive a short instructional session, secure the urinary drainage bag to the patient using the B3 Buddy device. Clinicians also assist patient with walking and then remove the device and return urinary drainage bag to the standard position on study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • PATIENT PARTICIPANT: Must be English-speaking
  • PATIENT PARTICIPANT: Able to comprehend and agree to consent
  • PATIENT PARTICIPANT: Able to read and complete the Acceptability of Implementation Measure (AIM) survey
  • PATIENT PARTICIPANT: Be willing to participate using the B3 Buddy device
  • PATIENT PARTICIPANT: Have an indwelling urinary catheter or urostomy device connected to a drainage bag
  • PATIENT PARTICIPANT: Have no restrictions in ambulation
  • CLINICIAN PARTICIPANT: Must be English-speaking
  • CLINICIAN PARTICIPANT: Able to comprehend and agree to consent
  • CLINICIAN PARTICIPANT: Able to read and complete the System Usability Scale (SUS) survey
  • CLINICIAN PARTICIPANT: Be willing to participate using the B3 Buddy device
  • CLINICIAN PARTICIPANT: Have a professional role in assisting patients in ambulation in normal workday activities
Exclusion Criteria
  • Those patient participants that have more than one urinary-like drainage bags will be excluded. This exclusion is due to the limited prototype samples available to the research team. Limiting one device for one patient with multiple drainage bags may not allow for accurate assessment of the B3 Buddy device

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Clinicians (B3 Buddy)RemoveClinicians receive a short instructional session, secure the urinary drainage bag to the patient using the B3 Buddy device. Clinicians also assist patient with walking and then remove the device and return urinary drainage bag to the standard position on study.
Clinicians (B3 Buddy)Educational InterventionClinicians receive a short instructional session, secure the urinary drainage bag to the patient using the B3 Buddy device. Clinicians also assist patient with walking and then remove the device and return urinary drainage bag to the standard position on study.
Clinicians (B3 Buddy)Medical Device Usage and EvaluationClinicians receive a short instructional session, secure the urinary drainage bag to the patient using the B3 Buddy device. Clinicians also assist patient with walking and then remove the device and return urinary drainage bag to the standard position on study.
Clinicians (B3 Buddy)AssistanceClinicians receive a short instructional session, secure the urinary drainage bag to the patient using the B3 Buddy device. Clinicians also assist patient with walking and then remove the device and return urinary drainage bag to the standard position on study.
Clinicians (B3 Buddy)Questionnaire AdministrationClinicians receive a short instructional session, secure the urinary drainage bag to the patient using the B3 Buddy device. Clinicians also assist patient with walking and then remove the device and return urinary drainage bag to the standard position on study.
Patients (B3 Buddy)Educational InterventionPatients receive a short instructional session, wear the B3 Buddy device to secure urinary drainage bag and walk approximately 90 feet before urinary drainage bag is returned to the standard position on study.
Patients (B3 Buddy)Medical Device Usage and EvaluationPatients receive a short instructional session, wear the B3 Buddy device to secure urinary drainage bag and walk approximately 90 feet before urinary drainage bag is returned to the standard position on study.
Patients (B3 Buddy)Questionnaire AdministrationPatients receive a short instructional session, wear the B3 Buddy device to secure urinary drainage bag and walk approximately 90 feet before urinary drainage bag is returned to the standard position on study.
Patients (B3 Buddy)WalkingPatients receive a short instructional session, wear the B3 Buddy device to secure urinary drainage bag and walk approximately 90 feet before urinary drainage bag is returned to the standard position on study.
Primary Outcome Measures
NameTimeMethod
Acceptability of DeviceUp to 17 minutes

The proportion of patients who find the device acceptable will be determined with the Acceptability of Implementation Measure tool. he AIM has 4 Likert items, ranging from 1 (for "completely disagree") to 5 (for "completely agree"). A higher number indicates greater acceptability. If a patient marked 3 or more items with at least a "4," the device was considered acceptable. The device will be considered acceptable if at least 70% of patient participants find the device acceptable, which will be calculated by survey responses.

Usability of DeviceUp to 20 minutes

Clinicians perception of usability will be determined with the System Usability Scale. The System Usability Scale score ranges from 0 to 100, where 100 represents the highest possible perceived usability. The device will be considered usable if the overall mean score is 68 or greater, which will be calculated by survey responses.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ohio State University Comprehensive Cancer Center

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath